• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Biodel Inc. (BIOD) - Financial and Strategic SWOT Analysis Review - Product Image

Biodel Inc. (BIOD) - Financial and Strategic SWOT Analysis Review

  • ID: 2081861
  • February 2014
  • 43 pages
  • GlobalData

Biodel Inc. (BIOD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list READ MORE >

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Biodel Inc. - Key Facts
Biodel Inc. - Key Employees
Biodel Inc. - Key Employee Biographies
Biodel Inc. - Major Products and Services
Biodel Inc. - Pharmaceutical Pipeline Products Data
Biodel Inc., Pipeline Products by Therapy Area
Biodel Inc., Pipeline Products by Development Phase
Biodel Inc. - Medical Equipment Pipeline Products Data
Biodel Inc. Pipeline Products by Equipment Type
Biodel Inc. Pipeline Products by Development Stage
Biodel Inc. - History
Biodel Inc. - Company Statement
Biodel Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Biodel Inc. - Business Description
Biodel Inc. - SWOT Analysis
SWOT Analysis - Overview
Biodel Inc. - Strengths
Strength - Liquidity Position
Strength - Strong Patent Portfolio
Biodel Inc. - Weaknesses
Weakness - Dependence on Third Parties
Weakness - Absence of Product Based Revenue
Biodel Inc. - Opportunities
Opportunity - Growing Aged Population
Opportunity - Market Potential: Type II Diabetes
Opportunity - Distribution Agreement: Pipeline Expansion
Biodel Inc. - Threats
Threat - Competition
Threat - Uncertain R&D Outcomes
Biodel Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Biodel Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Biodel Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Biodel Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
Biodel Inc., Medical Equipment, Deals By Type, 2008 to YTD 2014
Biodel Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
Biodel Inc., Recent Developments
Feb 06, 2014: Biodel Reports First Quarter Fiscal Year 2014 Financial Results
Dec 18, 2013: Biodel Reports Fourth Quarter Fiscal Year 2013 Financial Results
Dec 12, 2013: Biodel to Report Fourth Quarter Fiscal Year 2013 Financial Results on December 18, 2013
Aug 12, 2013: Biodel Reports Third Quarter Fiscal Year 2013 Financial Results
Aug 08, 2013: Biodel to Present at Wedbush 2013 Life Sciences Management Access Conference
Jul 02, 2013: Biodel Has Been Added to Russell Microcap Index
Jun 17, 2013: Biodel To Present Data From Human And Animal Studies With Its Ultra-rapid-acting Prandial Insulin Product Candidates At American Diabetes Association Annual Meeting
May 08, 2013: Biodel Reports Q2 Fiscal 2013 Results
May 06, 2013: Biodel to Report Second Quarter Fiscal Year 2013 Financial Results on May 8, 2013
Feb 12, 2013: Biodel Reports Q1 Fiscal 2013 Results
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Biodel Inc., Key Facts
Biodel Inc., Key Employees
Biodel Inc., Key Employee Biographies
Biodel Inc., Major Products and Services
Biodel Inc., Number of Pipeline Products by Therapy Area
Biodel Inc., Number of Pipeline Products by Development Stage
Biodel Inc., Pipeline Products By Therapy Area and Development Phase
Biodel Inc. Number of Pipeline Products by Equipment Type
Biodel Inc. Pipeline Products by Equipment Type
Biodel Inc. Number of Pipeline Products by Development Stage
Biodel Inc. Pipeline Products by Development Stage
Biodel Inc., History
Biodel Inc., Other Locations
Biodel Inc., Key Competitors
Biodel Inc., Ratios based on current share price
Biodel Inc., Annual Ratios
Biodel Inc., Interim Ratios
Biodel Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Biodel Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Biodel Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
Biodel Inc., Medical Equipment, Deals By Type, 2008 to YTD 2014
Biodel Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Biodel Inc., Pipeline Products by Therapy Area
Biodel Inc., Pipeline Products by Development Phase
Biodel Inc. Pipeline Products by Equipment Type
Biodel Inc. Pipeline Products by Development Stage
Biodel Inc., Performance Chart (2009 - 2013)
Biodel Inc., Ratio Charts
Biodel Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Biodel Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Biodel Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
Biodel Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014

Note: Product cover images may vary from those shown

RELATED PRODUCTS